Northern Trust’s Pharvaris PHVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.86M Sell
82,782
-686
-0.8% -$20.8K ﹤0.01% 2925
2026
Q1
$2.36M Buy
83,468
+2,433
+3% +$65K ﹤0.01% 2881
2025
Q4
$2.25M Buy
81,035
+3,080
+4% +$74.2K ﹤0.01% 2931
2025
Q3
$1.94M Sell
77,955
-17,314
-18% -$384K ﹤0.01% 3051
2025
Q2
$1.68M Buy
95,269
+8,393
+10% +$135K ﹤0.01% 3092
2025
Q1
$1.36M Sell
86,876
-5,056
-5% -$85.3K ﹤0.01% 3129
2024
Q4
$1.76M Buy
91,932
+76,188
+484% +$1.57M ﹤0.01% 3098
2024
Q3
$292K Buy
+15,744
New +$288K ﹤0.01% 3752

Other funds holding PHVS

Northern Trust's PHVS Position: Q2 2026 in Review

Northern Trust reduced its Pharvaris (PHVS) stake by 0.82% in Q2 2026, selling an estimated $20.8K and leaving 82,782 shares worth $2.86M. The position accounts for ﹤0.01% of the portfolio, ranked #2925.

Northern Trust first reported a position in PHVS in Q3 2024 and has held it in 8 quarters since. 125 funds tracked by Wall St. Rank hold PHVS as of Q2 2026.

  • Northern Trust held 82,782 shares of Pharvaris worth $2.86M as of Q2 2026.
  • Northern Trust sold 686 Pharvaris shares in Q2 2026, an estimated $20.8K.
  • Pharvaris made up ﹤0.01% of Northern Trust's portfolio in Q2 2026, its #2925 holding.
  • Northern Trust first reported a position in Pharvaris in Q3 2024 and has held it in 8 quarters since.
  • 125 funds tracked by Wall St. Rank held Pharvaris as of Q2 2026.

Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.